Clinical trial
A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of…
NCT00500201 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00500201 |
|---|---|
| Title | A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets. |
| Official title | A Single Blind, Double Dummy, Placebo Controlled, Randomized, 2 Period Crossover Study to Assess the Relative Bioavailability of a 120mg Tablet Compared to Two 60 mg SB-773812 Tablets in Healthy Volunteers |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | SB- 773812 60 mg, SB- 773812 120 mg, Placebo |
| Enrollment | 18 |
| Start date | May 24, 2007 |
| Primary completion | Jul 25, 2007 |
| Completion | Jul 25, 2007 |
| First posted | Jul 12, 2007 |
| Last update posted | Aug 8, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: